➤ Get the DrugPatentWatch Daily Briefing

Get Daily Updates on Generic Entry, Litigation, Biosimilars, and more …

Serving leading biopharmaceutical companies globally:

McKinsey
Harvard Business School
Mallinckrodt
Baxter
Merck
Moodys

Last Updated: August 5, 2020

DrugPatentWatch Database Preview

Bulk Pharmaceutical API Sources for glucagon

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Bulk Pharmaceutical API Sources for glucagon

Vendor Vendor Homepage Vendor Sku API Url
MolPort   Start Trial MolPort-003-938-762   Start Trial
ISpharm   Start Trial I06-1839   Start Trial
Chembase.cn   Start Trial 153945   Start Trial
Finetech Industry Limited   Start Trial FT-0626717   Start Trial
Aurora Fine Chemicals LLC   Start Trial A17.901.467   Start Trial
Parchem   Start Trial 29077   Start Trial
AbovChem LLC   Start Trial HY-P0082   Start Trial
>Vendor >Vendor Homepage >Vendor Sku >API Url

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Express Scripts
Dow
Mallinckrodt
Baxter
McKinsey
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.